Denmark investigates Novo Nordisk

2 April 2006

The Danish Public Prosecutor has decided to initiate preliminary investigational steps against a number of Danish companies, including Novo Nordisk, in connection with these companies' trading with the Iraqi authorities under the United Nations Oil-For-Food Program, the company announced, noting that it has not yet been presented with the formal decision, and thus is not aware of its contents.

Novo Nordisk says it will immediately approach the Public Prosecutor and intends to fully cooperate to ensure a smooth and efficient procedure. At this time, the company said it cannot determine or predict the outcome of this matter. In addition, it cannot predict how long the investigation will take or when it will be able to provide additional information.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight